Neovasc_Logo-web-header.jpg
Neovasc to Announce Third Quarter 2019 Financial Results on Thursday, November 7, 2019
October 25, 2019 07:00 ET | Neovasc, Inc.
VANCOUVER, Oct. 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Initiates Commercial Release of AVANCE Steerable Introducer Designed to Enhance Physician Control for Complex Cardiac Procedures
October 01, 2019 08:00 ET | BioCardia, Inc.
SAN CARLOS, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the...
Eko Health
AI-Powered Digital Health Company Eko Closes $20 Million Series B to Continue the Fight Against Heart Disease
September 25, 2019 09:02 ET | Eko
San Francisco, CA, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Eko, a Silicon Valley-based digital health company building machine learning tools to fight heart disease, today announced it has secured $20...
ARCA Logo - JPEG.jpg
ARCA Biopharma President and CEO Dr. Michael Bristow to Present at HFSA 2019 Excellence in Translational Science Symposium
September 12, 2019 08:30 ET | ARCA biopharma, Inc.
WESTMINSTER, Colo., Sept. 12, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
ARCA Logo - JPEG.jpg
Arca Biopharma Announces Gencaro Atrial Fibrillation Clinical Data Selected for Presentation at HFSA 2019 Scientific Meeting
September 11, 2019 08:30 ET | ARCA biopharma, Inc.
WESTMINSTER, Colo., Sept. 11, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
Philips IntelliSpace Cardiovascular
Philips debuts innovations in ultrasound and enterprise informatics to advance cardiac care at ESC 2019
August 29, 2019 04:00 ET | Royal Philips
August 29, 2019 European debut of latest release of Philips EPIQ CVx cardiology ultrasound platform extends advanced automation capabilities to make exams faster and easier to conductPhilips...
Reports and Data.jpeg-01
Coronary Stents Market To Reach USD 15.37 Billion By 2026 | Reports And Data
August 26, 2019 11:21 ET | Reports and Data
New York, Aug. 26, 2019 (GLOBE NEWSWIRE) -- High prevalence of coronary artery disease, changes in lifestyles and a rise in the geriatric population are the key factors contributing to the CAGR in...
HeartStart Intrepid v1
Philips unveils HeartStart Intrepid with IntelliSpace Connect across Europe and select markets worldwide
August 19, 2019 04:00 ET | Royal Philips
August 19, 2019 Enhanced communication and seamless data sharing capabilities augment clinical and operational efficiencies for patient assessment across emergency care settings Amsterdam,...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Announces Closing of $10.0 Million Public Offering
August 06, 2019 16:05 ET | BioCardia, Inc.
SAN CARLOS, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NasdaqCM: BCDA, BCDAW), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Signs Exclusive Development Agreement With AstraZeneca
July 25, 2019 06:00 ET | BioCardia, Inc.
SAN CARLOS, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...